Skip to content

MDMA and memory.

EFFECTS OF A SINGLE DOSE OF ±3.4 METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ON MEMORY PERFORMANCE: A PLACEBO CONTROLLED PHARMACO-FMRI STUDY.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24391
Enrollment
16
Registered
2008-08-25
Start date
2005-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MDMA induced memory impairment

Interventions

Single doses of MDMA 75mg and placebo.

Sponsors

Dr J.G.Ramaekers Dept of Neuropsychology & Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University. Email: j.ramaekers@psychology.unimaas.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Experience with the use of MDMA (at least 5 times in the past 12 months); 2. Free from psychotropic medication; 3. Good physical health as determined by examination and laboratory analysis; 4. Absence of any major medical (except OAC), endocrine and neurological condition; 5. Normal weight, body mass index (weight/length2) between 18 and 28 kg/m2; 6. Found suitable for fMRI as confirmed by the fMRI checklist; 7. Written Informed Consent.

Exclusion criteria

Exclusion criteria: 1. History of drug abuse (other than the use of MDMA) or addiction; 2. Pregnancy or lactation; 3. Cardiovascular abnormalities as assessed by standard 12-lead ECG; 4. Excessive drinking (> 20 alcoholic consumptions a week); 5. Hypertension (diastolic> 100; systolic> 170); 6. Current or history of psychiatric disorder; 7. Presence of metal substances/parts in the body (fMRI exclusion criterium).

Design outcomes

Primary

MeasureTime frame
1. Prospective and verbal memory; 2. Performance (behavior) and BOLD; 3. Response (during prospective memory task).

Secondary

MeasureTime frame
RT and no of correct responses.

Contacts

Public ContactJ.G. Ramaekers

Maastricht University Dept of Neuropsychology & Psychopharmacology, Faculty of Psychology and Neuroscience, P.O. Box 616

J.Ramaekers@psychology.unimaas.nl+31 (0)43 3881951

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)